Augmedix announced the early access release of the newest product on its platform, Augmedix Go, a clinician-controlled mobile app that uses generative AI to instantaneously create a fully automated draft medical note after each patient visit. Augmedix Go harnesses proprietary natural language processing, large language models, and structured data sets, key components of Augmedix’s tech stack. This powerful technology is utilized in a thoughtful manner to ensure comprehensive and highly accurate medical notes with appropriate guardrails that safeguard against errors. “As we pursue our goal of freeing clinicians from administrative burdens to focus on patient care, we are proud to deliver Augmedix Go. This fully automated product is an important milestone highlighting how we are responsibly harnessing the power of AI,” said Manny Krakaris, Chief Executive Officer of Augmedix. “Augmedix Go is a highly scalable product that is priced at a level to appeal to a broad base of healthcare systems. Generative AI is a powerful tool, and we are committed to engendering the trust of clinicians through a transparent user interface that also provides clinicians controls to tailor medical notes to their unique needs.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on AUGX:
- Augmedix Announces New AI Medical Documentation Product, Augmedix Go, a Clinician-Controlled Mobile App
- Augmedix announces inaugural AI Advisory Council members
- Augmedix Announces Inaugural AI Advisory Council Members
- Augmedix expands to behavioral healthcare field
- Augmedix achieves HITRUST certification
